SUPERNUS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Supernus Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Supernus Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 55.2M shares, a 1.78% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 55.2M +965K +1.78% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 55M +792K +1.46% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 54.7M +470K +0.87% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 54.7M +470K +0.87% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 54.3M +998K +1.87% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 54.3M +998K +1.87% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 54.3M +998K +1.87% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 54.3M +998K +1.87% Dec 31, 2022 10-Q 2023-11-08
Q3 2022 53.3M +388K +0.73% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 53.3M +388K +0.73% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 53.3M +388K +0.73% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 53.3M +388K +0.73% Dec 31, 2021 10-K 2023-03-09
Q3 2021 52.9M +198K +0.38% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 52.9M +244K +0.46% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 52.9M +331K +0.63% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 52.9M +335K +0.64% Dec 31, 2020 10-K 2022-04-13
Q3 2020 52.7M +207K +0.4% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 52.6M +175K +0.33% Jun 30, 2020 10-Q 2020-08-17
Q1 2020 52.5M +163K +0.31% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 52.5M +217K +0.41% Dec 31, 2019 10-K 2021-03-08
Q3 2019 52.5M +206K +0.39% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 52.4M +270K +0.52% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 52.4M +740K +1.43% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 52.3M +1M +1.95% Dec 31, 2018 10-K 2020-02-28
Q3 2018 52.3M +995K +1.94% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 52.2M +1.45M +2.85% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 51.6M +1.41M +2.8% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 51.3M +1.34M +2.69% Dec 31, 2017 10-K 2019-03-01
Q3 2017 51.3M +1.72M +3.48% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 50.7M +1.23M +2.48% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 50.2M +805K +1.63% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 50M +967K +1.97% Dec 31, 2016 10-K 2018-03-01
Q3 2016 49.5M +853K +1.75% Sep 30, 2016 10-Q 2017-01-20
Q2 2016 49.5M +1.06M +2.2% Jun 30, 2016 10-Q/A 2017-01-23
Q1 2016 49.4M +1.91M +4.02% Mar 31, 2016 10-Q/A 2017-01-20
Q4 2015 49M +6.03M +14% Dec 31, 2015 10-K 2017-03-16
Q3 2015 48.7M +5.76M +13.4% Sep 30, 2015 10-Q/A 2017-01-20
Q2 2015 48.4M +6.31M +15% Jun 30, 2015 10-Q/A 2017-01-23
Q1 2015 47.5M +5.47M +13% Mar 31, 2015 10-Q/A 2017-01-20
Q4 2014 43M +2.99M +7.48% Dec 31, 2014 10-K/A 2017-01-20
Q3 2014 42.9M +12M +38.7% Sep 30, 2014 10-Q/A 2017-01-20
Q2 2014 42.1M Jun 30, 2014 10-Q 2014-08-12
Q1 2014 42M +11.2M +36.1% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 40M +9.36M +30.6% Dec 31, 2013 10-K 2015-03-12
Q3 2013 30.9M +6.48M +26.5% Sep 30, 2013 10-Q 2013-11-13
Q1 2013 30.9M +29.2M +1736% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 30.6M +29M +1742% Dec 31, 2012 10-K 2014-03-21
Q3 2012 24.5M Sep 30, 2012 10-Q 2012-11-02
Q2 2012 24.5M Jun 30, 2012 10-Q 2012-08-13
Q1 2012 1.68M Mar 31, 2012 10-Q 2012-06-08
Q4 2011 1.66M Dec 31, 2011 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.